Compass Pathways Phase 3: What the Results Mean for Your Practice
Compass Pathways Phase 3: What the Results Mean for Your Practice
A regulatory path for psilocybin is no longer theoretical. Today, we are watching it unfold in real time.
On February 17th, 2026, Compass Pathways released successful Phase 3 data for psilocybin-assisted therapy with COMP360, their proprietary synthetic psilocybin formulation. With over 1,000 participants and consistent, statistically significant results, Compass is now targeting FDA filing by Q4 2026. That’s very soon.
This isn’t just a win for biotechnology; it is a turning point that will accelerate the entire psychedelic sector, now.
Collectively, we are no longer asking whether psilocybin works. We are in the phase of building the professional infrastructure to deliver it to the masses. This change matters even if you are NOT a clinician, since rescheduling will open up new opportunities for practitioners, facilitators, integration specialists, and other trained professionals.
The demand for industry-leading practitioners has already been outpacing the current supply. We’re likely to see this gap widen faster than ever before.
Will you step forward and lead this field with integrity? Or will you start from scratch and try to build a compliant practice when the doors fully open?
Join Paul F. Austin on February 19th at 10 AM PT / 1 PM ET as he breaks down exactly what this milestone means for your professional future.
Phase 3 Breakdown:
Why the COMP360 results are a "remarkable achievement" for psychiatry, according to Compass Pathways CEO Kabir Nath, plus what the rolling FDA submission means for the industry timeline.
The Practitioner Gap:
Why clinical success creates a massive demand for non-clinical integration specialists and coaches.
Future-Proofing Your Practice:
How to invest in training and credibility now so your credentials are in place for the next wave of psychedelic access.
The Professional Pathway:
How our Practitioner Certification Program provides the real-world mentorship and supervised client experience needed for this new era.
Direct Q&A:
Get Paul's perspective on how to differentiate your practice in a market that is rapidly moving from the fringes to the mainstream.

Paul F. Austin
Presenter